News

6. April 2016

Probiodrug AG

Probiodrug to hold its Ordinary General Meeting of Shareholders on May 19, 2016

4. April 2016

Probiodrug AG

Probiodrug announces results of chronic toxicology studies with PQ912, its 'first in class' Glutaminyl Cyclase (QC) inhibitor for the treatment of Alzheimer's disease

Favourable results enable longer patient treatment

31. März 2016

Probiodrug AG

Probiodrug to Present and Attend European Conferences in April 2016

23. März 2016

Probiodrug AG

Probiodrug Appoints Mark Booth as Chief Business Officer

Expands Management Board with Senior Hire

15. März 2016

Probiodrug reports full year 2015 financial results

Phase 2a study of novel treatment for Alzheimer's disease initiated

Phase 1 PQ912 data, a first in class Glutaminyl Cyclase (QC) inhibitor for the treatment of AD, prominently published

Private Placement completed raising EUR 13.5 million

9. März 2016

Probiodrug AG

Probiodrug's pGlu-Abeta Approaches being presented at 14th AAT Symposium on Advances in Alzheimer Therapy

The Symposium will be held from 9 to 12 March 2016 at the Athens Hilton in Athens, Greece

7. März 2016

Probiodrug AG

Probiodrug AG to Publish its Full Year 2015 Results on March 15, 2016

25. Februar 2016

Emperra GmbH

Intuitives Diabetes-Management für insulinpflichtige Menschen mit Diabetes
Digitaler Helfer: Erste Diabetes-App mit vollautomatischem Datenimport auch aus Insulinpens

22. Februar 2016

Probiodrug AG

Probiodrug to Attend and Present at European Conferences in March 2016

19. Februar 2016

UniNow GmbH

Mit UniNow organisiert durchs Studium – IBG-Fonds beteiligen sich an gleichnamigen Magdeburger Startup

Seiten